Skip to main content

Tumours of the Adrenal Gland

  • Chapter
  • First Online:
  • 1624 Accesses

Abstract

Adrenal or suprarenal tumours present a challenge to physicians and surgeons due to the variability in tumour type, clinical presentation and the effects of hormone secretion. A methodical approach to investigation and management is required in order to optimize outcomes and avoid the potential pitfalls that may occur with the management of these complex tumours. This chapter provides review of the investigation and management of all adrenal tumour types including adrenocortical carcinomas, phaeochromocytomas, Cushing’s and Conn’s syndrome.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Fung MM, Viveros OH, O’Connor DT. Diseases of the adrenal medulla. Acta Physiol. 2008;192(2):325–35.

    Article  CAS  Google Scholar 

  2. Skandalakis LJ, Skandalakis JE, Skandalakis PN. Adrenal glands. In: Surgical anatomy and technique of adrenal gland. New York: Springer; 2009. p. 603–30.

    Chapter  Google Scholar 

  3. Ilias I, Sahadev A, Reznik R, Grossman A, Pacak K. The optimal imaging of adrenal tumours: a comparison of different methods. Endocr Relat Cancer. 2007;14:587–99.

    Article  PubMed  Google Scholar 

  4. Sahdev A, Reznek RH. Imaging evaluation of the nonfunctioning indeterminate adrenal mass. Trends Endocrinol Metab. 2004;15:271–6.

    Article  CAS  PubMed  Google Scholar 

  5. Lockhart ME, Smith JK, Kenney PJ. Imaging of adrenalmasses. Eur J Radiol. 2002;41:95–112.

    Article  PubMed  Google Scholar 

  6. Boland GW, Dwamena BA, Jagtiani Sangwaiya M, Goehler AG, et al. Characterization of adrenalmasses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology. 2011;259:117–26.

    Article  PubMed  Google Scholar 

  7. Maurea S, Imbriaco M, Mollica C, Pace L, Salvatore M. Quantitative imaging characterization of hypersecreting or nonhypersecreting adrenal adenomas: comparison between iodine-131 norcholesterol uptake and magnetic resonance signal intensity ratios. Nucl Med Commun. 2011;32(6):535–41.

    Article  CAS  PubMed  Google Scholar 

  8. Burton TJ, Mackenzie IS, Balan K, Koo B, et al. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn’s adenomas. J Clin Endocrinol Metab. 2012;97:100–9.

    Article  CAS  PubMed  Google Scholar 

  9. Schulz C, Eisenhofer G, Lehnert H. Principles of catecholamine biosynthesis, metabolism and release. Front Horm Res. 2004;31:1–2.

    Article  CAS  PubMed  Google Scholar 

  10. Francis IR, Glazer GM, Shapiro B, Sisson JC, Gross BH. Complementary roles of CT and 131I-MIBG scintigraphy in diagnosing pheochromocytoma. AJR Am J Roentgenol. 1983;141:719–25.

    Article  CAS  PubMed  Google Scholar 

  11. Navalkissoor S, Alhashimi DM, Quigley AM, et al. Efficacy of using a standard activity of (131)I-MIBG therapy in patients with disseminated neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2010;37(5):904–12.

    Article  PubMed  Google Scholar 

  12. Aron D, Terzolo M, Cawood TJ. Adrenal incidentalomas. Best Pract Res Clin Endocrinol Metab. 2012;26:69–82.

    Article  PubMed  Google Scholar 

  13. Willatt JM, Francis IR. Radiologic evaluation of incidentally discovered adrenal masses. Am Fam Physician. 2010;81:1361–6.

    PubMed  Google Scholar 

  14. Zeiger M, Siegelman S, Hamrahian A. Medical and surgical evaluation and treatment of adrenal incidentalomas. J Clin Endocrinol Metab. 2011;96:2004–15.

    Article  CAS  PubMed  Google Scholar 

  15. Hedeland H, Ostberg G, Hokfelt B. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand. 1968;184(3):211–4.

    CAS  PubMed  Google Scholar 

  16. Garz G, Luning M, Melzer B. Computed tomographic incidental finding of a hormone-inactive adrenal cortex adenoma. Radiol Diagn (Berl). 1985;26(6):761–6.

    CAS  Google Scholar 

  17. Mantero F, Terzolo M, Arnaldi G, Osella G, et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab. 2000;85:637–44.

    CAS  PubMed  Google Scholar 

  18. Allolio B. Adrenal incidentalomas. In: Chrousos GP, Margioris AN, editors. Adrenal disorders. Totowa: Humana Press Inc; 2001. p. 249–61.

    Chapter  Google Scholar 

  19. Zeiger MA, Thompson GB, Duh Q-Y, et al. American association of clinical endocrinologists and American association of endocrine surgeons Medical guidelines for the management of adrenal incidentalomas. Endo Pract. 2009;15 Suppl 1:1–20.

    Article  Google Scholar 

  20. Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med. 2003;138:424–9.

    Article  PubMed  Google Scholar 

  21. Gordon RD, Stowasser M, Tunny TJ, et al. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol. 1994;21:315–8.

    Article  CAS  PubMed  Google Scholar 

  22. Moreira Jr SG, Pow-Sang JM. Evaluation and management of adrenal masses. Cancer Control. 2002;9:326–34.

    PubMed  Google Scholar 

  23. Kasperlik-Zeluska AA, Roslonowska E, Slowinska-Srzednicka J, et al. Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208patients. Clin Endocrinol. 1997;46:29–37.

    Article  CAS  Google Scholar 

  24. Kloos RT, Gross MD, Francis IR, et al. Incidentally discovered adrenal masses. Endocr Rev. 1995;16:460–84.

    CAS  PubMed  Google Scholar 

  25. Stein PP, Black HR. A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution’s experience. Medicine (Baltimore). 1991;70:46–66.

    Article  CAS  Google Scholar 

  26. Plotz C, Knowlton MAI, Ragan A. The natural history of Cushing’s syndrome. Am J Med. 1952;13:597–614.

    Article  CAS  PubMed  Google Scholar 

  27. Drake WM, Perry LA, Hinds CJ, Lowe DJ, et al. Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing’s syndrome and peritonitis. J Clin Endocrinol Metab. 1998;83:3542–4.

    CAS  PubMed  Google Scholar 

  28. Sbiera S, Schmull S, Assie G, et al. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. J Clin Endocrinol Metab. 2010;95:E161–71.

    Article  CAS  PubMed  Google Scholar 

  29. Allolio B, Hahner S, Weismann D, Fassnacht M. Management of adrenocortical carcinoma. Clin Endocrinol. 2004;60:273–87.

    Article  Google Scholar 

  30. Luton JP, Cerdas S, Billaud L, et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med. 1990;322:1195–201.

    Article  CAS  PubMed  Google Scholar 

  31. Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, et al. Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med. 2012;366:2189–97.

    Article  CAS  PubMed  Google Scholar 

  32. Erlandson RA, Reuter VE. Oncocytic adrenal cortical adenoma. Ultrastruct Pathol. 1991;15(4–5):539–47.

    Article  CAS  PubMed  Google Scholar 

  33. Sasano H, Suzuki T, Sano T, et al. Adrenocortical oncocytoma. A true nonfunctioning adrenocortical tumor. Am J Surg Pathol. 1991;15:949–56.

    Article  CAS  PubMed  Google Scholar 

  34. Neri LM, Nance FC. Management of adrenal cysts. Am Surg. 1999;65:151–63.

    CAS  PubMed  Google Scholar 

  35. Beard CM, Carney JA, Sheps SG, et al. Incidence of phaeochromocytoma. J Hum Hypertens. 1989;3:481.

    CAS  PubMed  Google Scholar 

  36. Donis-Keller H, Dou S, Chi D, et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet. 1993;2:851–6.

    Article  CAS  PubMed  Google Scholar 

  37. Eng C, Clayton D, Schuffenecker I, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type2. International RET mutation consortium analysis. JAMA. 1996;276:1575–9.

    Article  CAS  PubMed  Google Scholar 

  38. Vargas HI, Kavoussi LR, Bartlett DL, et al. Laparoscopic adrenalectomy: a new standard of care. Urology. 1997;49:673–8.

    Article  CAS  PubMed  Google Scholar 

  39. Loh KC, Fitzgerald PA, Matthay KK, et al. The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest. 1997;20:648–58.

    Article  CAS  PubMed  Google Scholar 

  40. Nitschke R, Smith EI, Shochat S, et al. Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study. J Clin Oncol. 1998;6:1271–9.

    Google Scholar 

  41. Rosen EM, Cassady JR, Frantz CN, et al. Neuroblastoma: the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children’s Hospital experience. J Clin Oncol. 1984;2:719–32.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shern L. Chew BSc, MB, BChir, MD, FRCP .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Greener, V., Chew, S.L. (2015). Tumours of the Adrenal Gland. In: Nargund, V., Raghavan, D., Sandler, H. (eds) Urological Oncology. Springer, London. https://doi.org/10.1007/978-0-85729-482-1_25

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-482-1_25

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-481-4

  • Online ISBN: 978-0-85729-482-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics